Peter Laivins
9Patents
6h-index
6Co-inventors
48Inventor score
Filing activity: Jun 12, 2013 → May 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9339497B2 | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | Human Necessities | 16 | Active |
| US9492442B2 | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | Human Necessities | 16 | Active |
| US9717724B2 | Methods for treating pancreatic cancer using combination therapies | Human Necessities | 12 | Active |
| US9364473B2 | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | Human Necessities | 11 | Active |
| US9452162B2 | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | Human Necessities | 11 | Active |
| US10980795B2 | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | Human Necessities | 7 | Active |
| US11369597B2 | Methods for treating pancreatic cancer using combination therapies | Human Necessities | 3 | Active |
| US10744130B2 | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | General | 0 | Revoked |
| US12364691B2 | Methods for treating pancreatic cancer using combination therapies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.